Table 3.

Adjusted survival analysis for 30- and 180-day all-cause death endpoints

	30 Day All-Cause Death*		30-Day All-Cause Death/ HF Rehospitalization*		180-Day All-Cause Death*
Group Comparison	OR (95% CI)	P-Value	OR (95% CI)	P-Value	HR (95% CI)	P-Value
Group 2 vs. Group 1	0.87 (0.60–1.27)	0.477	1.08 (0.87–1.36)	0.482	0.92 (0.69–1.22)	0.5578
Group 3 vs. Group 1	0.94 (0.73–1.22)	0.652	0.88 (0.74–1.07)	0.139	1.03 (0.83–1.28)	0.7734
Group 4 vs. Group 1	1.24 (1.00–1.54)	0.050	1.25 (1.08–1.43)	0.002	1.05 (0.86–1.29)	0.6225

Group 1 = No JVP or peripheral edema; Group 2 = JVP only; Group 3 = Peripheral edema only; Group 4 = Both JVP and peripheral edema.

^*Adjusted for age, baseline BUN (log), cerebrovascular disease, baseline creatinine (log), depression, dyspnea, prior HF hospitalization is past year, baseline sodium, baseline SBP, chronic renal disease, and BNP (standardized).

CI=confidence interval; HR=hazard ratio; OR=odds ratio